Skip to content
Review Open access

Beyond phenotypic markers: rethinking dopaminergic identity in iPSC-derived neurons

Sep 2026 · Cell Communication and Signaling · Vol 24 · 0 citations · 74 references
Medicine

Abstract

Human pluripotent stem cell-derived dopaminergic neurons have become central platforms for Parkinson’s disease (PD) modeling and regenerative medicine. Current differentiation systems can efficiently generate TH+/FOXA2+/LMX1A+ ventral midbrain-like populations. Although canonical markers remain important components of dopaminergic validation, the field increasingly complements them with single-cell profiling, developmental reference mapping, functional assessment, and transplantation-based evaluation. Nevertheless, marker-positive phenotypic resemblance alone may inadequately capture the full multidimensional identity of substantia nigra pars compacta neurons. Recent single-cell, developmental, and organoid studies indicate that human dopaminergic neurons exist across highly specialized multidimensional states shaped by developmental trajectory, epigenetic regulation, metabolic adaptation, biological aging, and ecosystem-level interactions. On the basis of these observations, we hypothesize that some current in vitro systems may generate neurons with incomplete or context-dependent identity because of accelerated differentiation, strong exogenous patterning, resetting of age-associated features, incomplete metabolic maturation, and the absence of supporting cells and tissue-derived signals. We distinguish these experimentally observed limitations from their conceptual interpretation and propose a testable framework for evaluating dopaminergic identity across developmental, molecular, metabolic, functional, aging-related, and environmental dimensions. This framework identifies improved maturation, representation of biological age, metabolic resilience, and multicellular context as priorities for PD modeling and regenerative neuroscience.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.